Skip Ribbon Commands
Skip to main content
Dr Hartirathpal Kaur D/O Juspal Singh

Dr Hartirathpal Kaur



Singapore General Hospital

Specialty: Haematology, Haematology, Haematology

Sub-specialties: Transfusion Medicine, Thrombosis and Haemostasis, Vascular Anomalies

Clinical Appointments

  • Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Consultant SingHealth Duke-NUS Vascular Centre
  • Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Consultant National Cancer Centre SingaporeNational Cancer Centre Singapore


​Dr Hartirathpal graduated with MBBS from NUS Yong Loo Lin School of Medicine in 2009 and obtained her MRCP (UK) in 2013.  She then underwent specialist training in Haematology at Singapore General Hospital from 2014 to 2017. She is currently an Associate Consultant with the Department of Haematology at Singapore General Hospital as well as Blood Services Group, Health Sciences Authority. Her area of interests are in transfusion medicine and obstetric haematology.


  • MBBS (Singapore): 2009
  • MRCP (UK): 2013

Professional Appointments and Committee Memberships

  • Clinical Tutor – Yong Loo Lin School of Medicine, National University of Singapore
  • Associate Consultant, Blood Services Group, Health Sciences Authority
  • ​Member – Singapore Society of Haematology


  • ​Singapore Health Service Quality Award (Silver) 2017

Research Interests


  • Tay HM, Lai YF, Kong MC, See E, Yeang SH, Koh SK, et al. Generational performance of three point-of-care testing devices compared with standard laboratory measurement of the international normalised ratio across extended ranges. J Clin Pathol. 2019 Apr;72(4):311–5. 
  • Tan CW, Wong WH, Idros R, Chan YH, Kaur H, Tng ARK, et al. Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia. Ann Hematol. 2019 Apr;98(4):861–8. 
  • Ong SY, Phipps C, Kaur H, Tan L, Lee YS. Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma. Vol. 48, Annals of the Academy of Medicine, Singapore. Singapore; 2019. p. 298–300. 
  • Bruun MT, Yazer MH, Spinella PC, Titlestad K, Lozano M, Delaney M, et al. Vox Sanguinis International Forum on paediatric indications for blood component transfusion. Vox Sang. 2019 Jul;114(5):e36–90. 
  • Bruun MT, Yazer MH, Spinella PC, Titlestad K, Lozano M, Delaney M, et al. Vox Sanguinis International Forum on paediatric indications for blood component transfusion: Summary. Vox Sang. 2019 Jul;114(5):523–30. 
  • Tan CW, Wong WH, Tan CK, Chan YH, Kaur H, Lee LH, et al. The Influence of Race on Plasma Thrombin Generation In Healthy Subjects In Singapore. Clin Appl Thromb  Off J Int  Acad Clin Appl Thromb. 2018 Oct;24(7):1144–7. 
  •  W.H.Wong, H.Kaur, C.W.Tan, L.H.Lee, H.J.Ng. Cross-interference of rivaroxaban and enoxaparin on Berichrom anti-Xa heparin and Biophen Direct Xa Inhibitor assays. International Journal of Laboratory Haematology. 2018;1-3.
  • Kaur H, Yeang SH, See E, Grant D, Tan CW, Wong WH, et al. Reversal of rivaroxaban using Prothromplex Total, a 4-factor prothrombin complex. Vol. 156, Thrombosis research. United States; 2017. p. 117–8. 
  • W.H.Wong, C.K.Tan, L.P.Ho, C.W.Tan, H.Kaur, L.H.Lee, H.J.Ng. Relevance of ethnic differences in factor XIII activity on laboratory reference ranges. International Journal of Laboratory Haematology, May 2017.
  • H.Kaur, J.C.C.Hwang, L.Y.K.Ho, X.Zhang, H.J.Ng. Extensive subcutaneous haematoma associated with transdermal analgesic patch in a Haemophilia A patient with inhibitor. Haemophilia. Vol.22 Issue 4. June 2016.   

Research Trials